Want to see VSEE full AI Analyst Report?
Top Page
VSee Health
(OTC:VSEE)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.01
▼(-30.00% Downside)
Action:Upgraded
Date:09/06/26
The score is driven primarily by weak financial performance (revenue contraction, very large losses, and persistent negative operating/free cash flow) and a technically weak setup (price below all major moving averages with negative MACD). Valuation provides limited support because losses make the negative P/E less meaningful and no dividend yield is available.
Positive Factors
Recurring telehealth and RPM business model
The combination of telehealth software and remote patient monitoring supports recurring subscription and enterprise-contract revenue. Its HIPAA-compliant platform and workflow tools can become embedded in provider operations, potentially supporting retention and scalable growth as virtual care adoption expands.
Negative Factors
Revenue contraction and sustained unprofitability
Revenue contraction alongside a deeply negative net margin indicates that the current revenue base is not yet sufficient to support the cost structure. Persistent operating losses weaken reinvestment capacity and make a durable path to profitability dependent on renewed growth or substantial cost reductions.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring telehealth and RPM business model
The combination of telehealth software and remote patient monitoring supports recurring subscription and enterprise-contract revenue. Its HIPAA-compliant platform and workflow tools can become embedded in provider operations, potentially supporting retention and scalable growth as virtual care adoption expands.
Read all positive factors
VSee Health (VSEE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$901.21K
Dividend YieldN/A
Average Volume (3M)14.01M
Price to Earnings (P/E)―
Beta (1Y)0.50
Revenue Growth-9.31%
EPS Growth89.43%
CountryUS
Employees209
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding56,679,813
10 Day Avg. Volume1,272,862
30 Day Avg. Volume14,009,307
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VSee Health Business Overview & Revenue Model
Company Description
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care envi...
How the Company Makes Money
VSee Health primarily makes money by selling access to its telehealth and RPM software as recurring subscriptions and enterprise contracts. Revenue is typically generated through: (1) software licensing / SaaS fees for use of its HIPAA-compliant v...
VSee Health Financial Statement Overview
Summary
Income Statement
23
Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.63M | 14.62M | 10.42M | 5.77M | 6.38M | 7.34M |
| Gross Profit | 4.76M | 7.36M | 7.18M | 3.83M | 4.84M | 5.92M |
| EBITDA | -9.03M | -9.18M | -3.36M | -1.79M | 0.00 | 386.34K |
| Net Income | -13.82M | -14.71M | -57.70M | -3.76M | -836.21K | 475.90K |
Balance Sheet | ||||||
| Total Assets | 16.73M | 22.41M | 19.99M | 805.79K | 2.61M | 117.94M |
| Cash, Cash Equivalents and Short-Term Investments | 454.15K | 5.27M | 326.12K | 118.73K | 230.66K | 760.01K |
| Total Debt | 1.88M | 2.44M | 9.55M | 543.00K | 517.13K | 0.00 |
| Total Liabilities | 9.14M | 16.96M | 20.01M | 5.11M | 2.61M | 4.55M |
| Stockholders Equity | 7.59M | 5.45M | -18.49K | -3.97M | 360.72K | 113.39M |
Cash Flow | ||||||
| Free Cash Flow | -5.20M | -3.48M | -5.84M | -636.93K | -1.45M | -600.11K |
| Operating Cash Flow | -6.31M | -3.45M | -5.79M | -632.60K | -1.45M | -600.11K |
| Investing Cash Flow | -143.21K | -29.93K | -26.14K | -4.33K | 110.12M | -116.73M |
| Financing Cash Flow | 6.83M | 8.42M | 6.02M | 525.00K | -109.32M | 118.09M |
VSee Health Technical Analysis
Negative
0.02
Price Trends
0.06
Negative
0.12
Negative
0.25
Negative
Market Momentum
-0.01
Negative
34.56
Neutral
54.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VSEE, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.06, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 34.56 is Neutral, neither overbought nor oversold. The STOCH value of 54.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VSEE.
VSee Health Risk Analysis
VSee Health disclosed 62 risk factors in its most recent earnings report. VSee Health reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
VSee Health Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $220.94M | -2.72 | -33.27% | ― | -19.00% | 40.98% | |
52 Neutral | $1.14B | -6.34 | -13.08% | ― | -2.08% | 16.88% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | $983.99K | >-0.01 | -32.44% | ― | -28.30% | -86.74% | |
41 Neutral | $901.21K | -0.04 | -400.87% | ― | -9.31% | 89.43% |
* Healthcare Sector Average
VSEE
VSee Health
0.02
-0.65
-97.75%
TDOC
Teladoc
6.28
-1.56
-19.90%
ZCMD
Zhongchao
0.85
-758.03
-99.89%
AMWL
American Well
12.99
6.08
87.99%
ONMD
OneMedNet
0.68
-0.17
-19.88%
EUDA
EUDA Health Holdings
13.49
-16.51
-55.03%
VSee Health Corporate Events
Executive/Board ChangesShareholder MeetingsStock Split
VSee Health Shareholders Approve Reverse Split Flexibility
Positive
Aug 26, 2026
On August 25, 2026, VSee Health, Inc. held its annual meeting of stockholders for the fiscal year ended December 31, 2026, with a quorum representing 50.65% of voting shares present in person or by proxy. Shareholders elected directors Kevin Lowde...
Delistings and Listing ChangesRegulatory Filings and Compliance
VSee Health Faces Nasdaq Trading Suspension and Delisting
Negative
Aug 4, 2026
On September 24, 2025, VSee Health disclosed that it had fallen out of compliance with Nasdaq’s Bid Price Rule after its shares traded below $1.00 for 30 consecutive sessions, triggering an initial 180‑day cure period later extended to...
Business Operations and StrategyPrivate Placements and Financing
VSee Health Raises Capital Through Convertible Debt Financing
Neutral
Jul 31, 2026
On June 30, 2026, VSee Health, Inc. entered into a securities purchase agreement with institutional investor Labrys, issuing an unsecured convertible promissory note with a principal amount of $336,000, including a $36,000 original issue discount,...
Business Operations and StrategyLegal ProceedingsPrivate Placements and FinancingRegulatory Filings and Compliance
VSee Health Enters Financing Settlement with Key Lenders
Negative
Jul 24, 2026
On July 21, 2026, VSee Health, Inc. entered into a Settlement Agreement and Mutual Release with ADI Funding LLC and M2B Funding Corp. to resolve disputes related to a June 8, 2026 secured promissory note and associated equity line of credit financ...
Regulatory Filings and ComplianceShareholder Meetings
VSee Health Sets 2026 Annual Meeting and Deadlines
Neutral
Jul 10, 2026
On July 6, 2026, VSee Health, Inc.’s board ratified August 25, 2026 as the date of its 2026 annual meeting of stockholders and set July 6, 2026 as the record date for shareholders entitled to receive notice and vote. The company said further...
Business Operations and StrategyPrivate Placements and Financing
VSee Health Entering New Convertible Debt Financing Agreements
Negative
Jul 7, 2026
On June 22, 2026, VSee Health entered into a securities purchase agreement with institutional investor ClearThink, issuing an unsecured convertible note with a principal amount of $280,000, including a $30,000 original issue discount and a one-tim...
Legal ProceedingsPrivate Placements and FinancingRegulatory Filings and Compliance
VSee Health Faces Debt Default Trigger and Liquidity Risks
Negative
Jun 26, 2026
On June 12, 2026, VSee Health, Inc. disclosed that ADI Funding, LLC, the holder of its 8% original issue discount secured promissory note of approximately $271,739, had notified the company on June 11, 2026 that an Event of Default had occurred un...
Private Placements and FinancingRegulatory Filings and Compliance
VSee Health Establishes Standby Equity Financing Agreement
Neutral
Jun 11, 2026
On June 2, 2026, VSee Health, Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD., giving the company the right, subject to conditions including an effective resale registration statement, to sell up to $10 million of its com...
Private Placements and Financing
VSee Health Secures New Private Debt Financing Agreement
Neutral
Jun 11, 2026
On June 8, 2026, VSee Health, Inc. entered into a securities purchase agreement with an institutional investor and issued an 8% original issue discount secured promissory note with an aggregate principal amount of $271,739.13, bearing 18% annual i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.